Simvastatin causes the formation of cholesterol-rich remnants in mice lacking apoE
- 24 March 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 341 (4), 1172-1176
- https://doi.org/10.1016/j.bbrc.2006.01.071
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein CholesterolThe American Journal of Cardiology, 2005
- Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependentPublished by Elsevier ,2004
- Effects of Simvastatin on Plasma Lipoproteins and Response to Arterial Injury in Wild-Type and Apolipoprotein-E-Deficient MiceJournal of Vascular Research, 2004
- The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein EBiochemical Journal, 2003
- Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in MiceJournal of Biological Chemistry, 2003
- Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein EAtherosclerosis, 2002
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Apolipoprotein B: mRNA Editing, Lipoprotein Assembly, and Presecretory DegradationAnnual Review of Nutrition, 2000
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992